BFC Planning’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$59.4K Buy
333
+21
+7% +$3.43K ﹤0.01% 1467
2026
Q2
$46.8K Buy
312
+11
+4% +$1.2K ﹤0.01% 1585
2026
Q1
$27.8K Hold
301
– – ﹤0.01% 1568
2025
Q4
$30.7K Buy
301
+9
+3% +$805 ﹤0.01% 1561
2025
Q3
$18.2K Sell
292
-13
-4% -$707 ﹤0.01% 1619
2025
Q2
$15.9K Hold
305
– – ﹤0.01% 1601
2025
Q1
$13K Buy
305
+13
+4% +$561 ﹤0.01% 1653
2024
Q4
$8.92K Hold
292
– – ﹤0.01% 1812
2024
Q3
$6.7K Buy
+292
New +$8.26K ﹤0.01% 1905

Other funds holding GH

BFC Planning's GH Position: Q3 2026 in Review

BFC Planning increased its Guardant Health (GH) stake by 6.7% in Q3 2026, buying an estimated $3.43K and bringing the position to 333 shares worth $59.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

BFC Planning first reported a position in GH in Q3 2024 and has held it in 9 quarters since. 526 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • BFC Planning held 333 shares of Guardant Health worth $59.4K as of Q3 2026.
  • BFC Planning bought 21 Guardant Health shares in Q3 2026, an estimated $3.43K.
  • Guardant Health made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1467 holding.
  • BFC Planning first reported a position in Guardant Health in Q3 2024 and has held it in 9 quarters since.
  • 526 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.